✦ LIBER ✦

Withdrawal of levodopa and other risk factors for malignant syndrome in Parkinson's disease

✍ Scribed by Takao Hashimoto; Takahiko Tokuda; Norinao Hanyu; Kenichi Tabata; Nobuo Yanagisawa

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Risk factors for levodopa-induced dyskin

✍ Grandas, F.; Galiano, Maria Luisa; Tabernero, Cesar 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 91 KB

2.234 RISK FACTORS FOR LEVODOPA-RELATED

✍ H. Zhang; S. Chen; N. Ren; Y. Liu 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 54 KB

Identification of possible risk factors

✍ Anne-Louise Cunnington; Lesley White; Kay Hood 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 100 KB

Neuroleptic Malignant Syndrome in Parkin

✍ Keyser, Daniel L. 📂 Article 📅 1991 🏛 American Medical Association 🌐 English ⚖ 550 KB

Which risk factors predict the levodopa

✍ M. W. I. M. Horstink; J. C. M. Zijlmans; J. W. Pasman; H. J. C. Berger; J. J. Ko 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 583 KB

Malignant deep brain stimulation-withdra

✍ Neuneier, Janina; Barbe, Michael T.; Dohmen, Christian; Maarouf, Mohammad; Wirth 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 245 KB